Nanalysis Scientific (TSXV:NSCI) Cash And Cash Equivalents : C$1.69 Mil (As of Mar. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Nanalysis Scientific Cash And Cash Equivalents?

Nanalysis Scientific's quarterly cash and cash equivalents declined from Sep. 2023 (C$1.27 Mil) to Dec. 2023 (C$0.76 Mil) but then increased from Dec. 2023 (C$0.76 Mil) to Mar. 2024 (C$1.69 Mil).

Nanalysis Scientific's annual cash and cash equivalents declined from Dec. 2021 (C$10.41 Mil) to Dec. 2022 (C$3.53 Mil) and declined from Dec. 2022 (C$3.53 Mil) to Dec. 2023 (C$0.76 Mil).

Nanalysis Scientific Cash And Cash Equivalents Historical Data

The historical data trend for Nanalysis Scientific's Cash And Cash Equivalents can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nanalysis Scientific Cash And Cash Equivalents Chart

Nanalysis Scientific Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Cash And Cash Equivalents

Get a 7-Day Free Trial

6.62

3.16

10.41

3.53

0.76

Nanalysis Scientific Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Cash And Cash Equivalents	Get a 7-Day Free Trial															1.76	4.95	1.27	0.76	1.69

Nanalysis Scientific Cash And Cash Equivalents Calculation

Cash and cash equivalents are the most liquid assets on the balance sheet. Cash equivalents are assets that are readily convertible into cash, such as money market holdings, short-term government bonds or Treasury bills, marketable securities and commercial paper.

Nanalysis Scientific (TSXV:NSCI) Cash And Cash Equivalents Explanation

A high number means either:

1) The company has competitive advantage generating lots of cash

2) Just sold a business or bonds (not necessarily good)

A low stockpile of cash usually means poor to mediocre economics.

There are 3 ways to create large cash reserve.

1) Sell new bonds or equity to public

2) Sell business or asset

3) It has an ongoing business generating more cash than it burns (usually means durable competitive advantage)

When a company is suffering a short term problem, Buffett looks at cash or marketable securities to see whether it has the financial strength to ride it out.

Important: Lots of cash and marketable securities + little debt = good chance that the business will sail on through tough times.

Test to see what is creating cash by looking at past 7 yrs of balance sheets. This will reveal how the cash was created.

Be Aware

Depreciation estimates make the calculation of net income susceptible to management's accounting choices. These choices can be either overly aggressive or overly conservative.

Nanalysis Scientific Cash And Cash Equivalents Related Terms

Thank you for viewing the detailed overview of Nanalysis Scientific's Cash And Cash Equivalents provided by GuruFocus.com. Please click on the following links to see related term pages.

Nanalysis Scientific (TSXV:NSCI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Technology » Hardware » Nanalysis Scientific Corp (TSXV:NSCI) » Definitions » Cash And Cash Equivalents

Comparable Companies

Traded in Other Exchanges

NSCIF:USA 1N1:Germany

Address

Bay 1, 4600 5th Street NE, Calgary, AB, CAN, T2E 7C3

Website

https://www.nanalysis.com

Nanalysis Scientific Corp designs, manufactures and sells a range of nuclear magnetic resonance (NMR) technologies that go into a range of NMR spectrometers and magnetic resonance imaging (MRI) equipment. The company's original product, the a 60 MHz MR spectrometer, was the first full-featured benchtop NMR spectrometer available on the market. Its operating segments are Nanalysis, RS2D, K'Prime and Corporate. Nanalysis is a patent-protected technology company that develops, manufactures, and sells compact magnetic resonance spectrometers (MR spectrometer) for the pharmaceutical, biotech, chemical, security, food, materials, and education industries. Geographic segments of the group are the U.S., Europe, Canada, Asia and Other regions.

Executives

Michal Okoniewski

Director

Nanalysis Scientific (TSXV:NSCI) Headlines

No Headlines